Page 1271 - Saunders Comprehensive Review For NCLEX-RN
P. 1271

to reduce energy expenditure at mealtimes.
                                             3. Assist the client in self-care and mobility activities.
                                             4. Allow adequate rest periods during care.
                                             5. Do not perform activities unless they are essential;
                                                assist the client in scheduling important or
                                                pleasurable activities during periods of highest
                                                energy.
                                             6. Administer blood products for anemia as prescribed.
                                F. Additional interventions
                                             1. Chemotherapy
                                                             a. Induction therapy is aimed at achieving
                                                                a rapid, complete remission of all
                                                                manifestations of the disease.
                                                             b. Consolidation therapy is administered
                                                                early in remission with the aim of
                                                                curing.
                                                             c. Maintenance therapy may be prescribed
                                                                for months or years after successful
                                                                induction and consolidation therapy;
                                                                the aim is to maintain remission.
                                             2. Administer antibiotic, antibacterial, antiviral, and
                                                antifungal medications as prescribed.
                                             3. Administer colony-stimulating factors as prescribed.
                                             4. Administer blood replacements as prescribed.
                                             5. Maintain infection and bleeding precautions.
                                             6. Prepare the client for transplantation if indicated.
                                             7. Instruct the client in appropriate home care measures.
                                             8. Provide psychosocial support and support services for
                                                home care.
                    X. Lymphoma: Hodgkin’s Disease
                                A. Description
                                             1. Lymphomas, classified as Hodgkin’s and non-
                                                Hodgkin’s depending on the cell type, are
                                                characterized by abnormal proliferation of
                                                lymphocytes.
                                             2. Hodgkin’s disease is a malignancy of the lymph nodes
                                                that originates in a single lymph node or a chain of
                                                nodes.
                                             3. Metastasis occurs to other, adjacent lymph structures
                                                and eventually invades nonlymphoid tissue.
                                             4. The disease usually involves lymph nodes, tonsils,
                                                spleen, and bone marrow and is characterized by the
                                                presence of Reed-Sternberg cells in the nodes.
                                             5. Possible causes include viral infections; clients treated
                                                with combination chemotherapy for Hodgkin’s
                                                disease have a greater risk of developing acute
                                                leukemia and non–Hodgkin’s lymphoma, among
                                                other secondary malignancies.



                                                         1271
   1266   1267   1268   1269   1270   1271   1272   1273   1274   1275   1276